Sean Whelan
CIK 1418307 · Chief Financial Officer · last filed 2025-11-18
Sean Whelan is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2014. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
-$5.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Zomedica Corp. (ZOM) Delisted | Director | — | $0.10 | — | $0 | 3 | 2024-11-13 |
| Diplomat Pharmacy, Inc. (DPLO) Delisted | Chief Financial Officer | 142,530 | — | — | -$5.66M | 4 | 2016-03-23 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-18 | — | Grant (A) | — | $0 | |
| 2024-11-13 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-13 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-23 | Diplomat Pharmacy, Inc. (DPLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-27 | Diplomat Pharmacy, Inc. (DPLO) Delisted | Mixed | +140,530 | -$4.44M | EDGAR |
| 2015-04-01 | Diplomat Pharmacy, Inc. (DPLO) Delisted | Disp (D) | — | $0 | EDGAR |
| 2014-10-10 | Diplomat Pharmacy, Inc. (DPLO) Delisted | Mixed | +2,000 | $26.0K | EDGAR |
| 2010-06-04 | — | Tax (F) | −5,775 | -$15.5K | |
| 2010-06-03 | — | Grant (A) | — | $0 |